BB Biotech AG 13D and 13G filings for Kezar Life Sciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:20 pm Sale | 2022-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BB Biotech AG | 300,000 4.400% | -191,815 (-39.00%) | Filing |
| 2022-02-11 4:41 pm Purchase | 2021-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BB Biotech AG | 491,815 9.200% | 38,500 (+8.49%) | Filing |
| 2021-02-12 4:52 pm Purchase | 2020-12-31 | 13G | Kezar Life Sciences, Inc. KZR | BB Biotech AG | 453,315 9.800% | 298,248 (+192.33%) | Filing |